Becton Dickinson stock falls 1.28 percent on September 24, 2026

Becton Dickinson stock was trading at USD 180.19 on the NYSE on September 24, 2026, at 2:56 p.m. ET, down 1.28 percent from USD 182.52. The price stood below the 52-week high of USD 193.07 as the medical technology company worked through a mixed fiscal third quarter.

Revenue reaches USD 5.0 billion

Fiscal Q3 2026 revenue reached USD 5.0 billion, up 4.4 percent year over year, while adjusted EPS came in at USD 3.23. Becton, Dickinson and Company published those figures for the quarter ended June 30, 2026.

The earnings mix matters because the top line expanded while profitability remained under pressure. Adjusted operating margin was 24.9 percent in fiscal Q3 2026, down 130 basis points from the prior year, according to the company report.

Guidance rises to USD 12.62 to USD 12.72

Becton Dickinson lifted its fiscal 2026 adjusted EPS guidance to a range of USD 12.62 to USD 12.72 after the quarterly performance. Investing.com reported that the company also moved its full-year revenue outlook toward the high end of its low-single-digit growth range.

The comparison between revenue and margin points to the central issue for the shares. Becton Dickinson is generating growth, but tariffs and portfolio-related effects are limiting how much of that growth reaches operating profit.

Stock stays below yearly high

At USD 180.19 on the NYSE on September 24, 2026, Becton Dickinson stock was USD 12.88 below its 52-week high and had a market capitalization of USD 49.649 billion. The combination of 4.4 percent revenue growth and a 130-basis-point margin decline leaves execution and cost control as the key measurable factors for the next report.